Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients — Stella

Home/Immunization; Infection/High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients

View on ClinicalTrials.gov

Recruiting

Back to Immunization; Infection trials

High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Vanderbilt University Medical Center, Nashville, Tennessee

Key details

Phase

Safety & dosing

Sponsor

Vanderbilt University Medical Center

Collaborators

Northwestern University Feinberg School of Medicine, University of Alabama at Birmingham

Enrollment target

~270 participants

Started

November 2022

Primary completion

July 2027

Age range

16 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.